Global Antibody Services Market Size, Status and Forecast 2024-2034
Global Antibody Services Scope and Market Size
Antibody Services market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antibody Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Monoclonal
Polyclonal
Others
Segment by Application
BioScience Companies
BioScience Research Institutions
Hospitals
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
ThermoFisher
GenScript
Abcam
MBS
ROCKLAND
ProSci
Anaspec
Bio-Rad
Covance
Capra Science
Innovagen
APS
Randox
GL Biochem
Abgent
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal
1.2.3 Polyclonal
1.2.4 Others
1.3 Market by Application
1.3.1 Global Antibody Services Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 BioScience Companies
1.3.3 BioScience Research Institutions
1.3.4 Hospitals
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antibody Services Market Perspective (2016-2027)
2.2 Antibody Services Growth Trends by Regions
2.2.1 Antibody Services Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antibody Services Historic Market Share by Regions (2016-2021)
2.2.3 Antibody Services Forecasted Market Size by Regions (2022-2027)
2.3 Antibody Services Industry Dynamic
2.3.1 Antibody Services Market Trends
2.3.2 Antibody Services Market Drivers
2.3.3 Antibody Services Market Challenges
2.3.4 Antibody Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Services Players by Revenue
3.1.1 Global Top Antibody Services Players by Revenue (2016-2021)
3.1.2 Global Antibody Services Revenue Market Share by Players (2016-2021)
3.2 Global Antibody Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antibody Services Revenue
3.4 Global Antibody Services Market Concentration Ratio
3.4.1 Global Antibody Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Services Revenue in 2020
3.5 Antibody Services Key Players Head office and Area Served
3.6 Key Players Antibody Services Product Solution and Service
3.7 Date of Enter into Antibody Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Services Breakdown Data by Type
4.1 Global Antibody Services Historic Market Size by Type (2016-2021)
4.2 Global Antibody Services Forecasted Market Size by Type (2022-2027)
5 Antibody Services Breakdown Data by Application
5.1 Global Antibody Services Historic Market Size by Application (2016-2021)
5.2 Global Antibody Services Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Antibody Services Market Size (2016-2027)
6.2 North America Antibody Services Market Size by Type
6.2.1 North America Antibody Services Market Size by Type (2016-2021)
6.2.2 North America Antibody Services Market Size by Type (2022-2027)
6.2.3 North America Antibody Services Market Size by Type (2016-2027)
6.3 North America Antibody Services Market Size by Application
6.3.1 North America Antibody Services Market Size by Application (2016-2021)
6.3.2 North America Antibody Services Market Size by Application (2022-2027)
6.3.3 North America Antibody Services Market Size by Application (2016-2027)
6.4 North America Antibody Services Market Size by Country
6.4.1 North America Antibody Services Market Size by Country (2016-2021)
6.4.2 North America Antibody Services Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Antibody Services Market Size (2016-2027)
7.2 Europe Antibody Services Market Size by Type
7.2.1 Europe Antibody Services Market Size by Type (2016-2021)
7.2.2 Europe Antibody Services Market Size by Type (2022-2027)
7.2.3 Europe Antibody Services Market Size by Type (2016-2027)
7.3 Europe Antibody Services Market Size by Application
7.3.1 Europe Antibody Services Market Size by Application (2016-2021)
7.3.2 Europe Antibody Services Market Size by Application (2022-2027)
7.3.3 Europe Antibody Services Market Size by Application (2016-2027)
7.4 Europe Antibody Services Market Size by Country
7.4.1 Europe Antibody Services Market Size by Country (2016-2021)
7.4.2 Europe Antibody Services Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Antibody Services Market Size (2016-2027)
8.2 Asia-Pacific Antibody Services Market Size by Type
8.2.1 Asia-Pacific Antibody Services Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antibody Services Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antibody Services Market Size by Type (2016-2027)
8.3 Asia-Pacific Antibody Services Market Size by Application
8.3.1 Asia-Pacific Antibody Services Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antibody Services Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antibody Services Market Size by Application (2016-2027)
8.4 Asia-Pacific Antibody Services Market Size by Region
8.4.1 Asia-Pacific Antibody Services Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antibody Services Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antibody Services Market Size (2016-2027)
9.2 Latin America Antibody Services Market Size by Type
9.2.1 Latin America Antibody Services Market Size by Type (2016-2021)
9.2.2 Latin America Antibody Services Market Size by Type (2022-2027)
9.2.3 Latin America Antibody Services Market Size by Type (2016-2027)
9.3 Latin America Antibody Services Market Size by Application
9.3.1 Latin America Antibody Services Market Size by Application (2016-2021)
9.3.2 Latin America Antibody Services Market Size by Application (2022-2027)
9.3.3 Latin America Antibody Services Market Size by Application (2016-2027)
9.4 Latin America Antibody Services Market Size by Country
9.4.1 Latin America Antibody Services Market Size by Country (2016-2021)
9.4.2 Latin America Antibody Services Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Services Market Size (2016-2027)
10.2 Middle East & Africa Antibody Services Market Size by Type
10.2.1 Middle East & Africa Antibody Services Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antibody Services Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antibody Services Market Size by Type (2016-2027)
10.3 Middle East & Africa Antibody Services Market Size by Application
10.3.1 Middle East & Africa Antibody Services Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antibody Services Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antibody Services Market Size by Application (2016-2027)
10.4 Middle East & Africa Antibody Services Market Size by Country
10.4.1 Middle East & Africa Antibody Services Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antibody Services Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 ThermoFisher
11.1.1 ThermoFisher Company Details
11.1.2 ThermoFisher Business Overview
11.1.3 ThermoFisher Antibody Services Introduction
11.1.4 ThermoFisher Revenue in Antibody Services Business (2016-2021)
11.1.5 ThermoFisher Recent Development
11.2 GenScript
11.2.1 GenScript Company Details
11.2.2 GenScript Business Overview
11.2.3 GenScript Antibody Services Introduction
11.2.4 GenScript Revenue in Antibody Services Business (2016-2021)
11.2.5 GenScript Recent Development
11.3 Abcam
11.3.1 Abcam Company Details
11.3.2 Abcam Business Overview
11.3.3 Abcam Antibody Services Introduction
11.3.4 Abcam Revenue in Antibody Services Business (2016-2021)
11.3.5 Abcam Recent Development
11.4 MBS
11.4.1 MBS Company Details
11.4.2 MBS Business Overview
11.4.3 MBS Antibody Services Introduction
11.4.4 MBS Revenue in Antibody Services Business (2016-2021)
11.4.5 MBS Recent Development
11.5 ROCKLAND
11.5.1 ROCKLAND Company Details
11.5.2 ROCKLAND Business Overview
11.5.3 ROCKLAND Antibody Services Introduction
11.5.4 ROCKLAND Revenue in Antibody Services Business (2016-2021)
11.5.5 ROCKLAND Recent Development
11.6 ProSci
11.6.1 ProSci Company Details
11.6.2 ProSci Business Overview
11.6.3 ProSci Antibody Services Introduction
11.6.4 ProSci Revenue in Antibody Services Business (2016-2021)
11.6.5 ProSci Recent Development
11.7 Anaspec
11.7.1 Anaspec Company Details
11.7.2 Anaspec Business Overview
11.7.3 Anaspec Antibody Services Introduction
11.7.4 Anaspec Revenue in Antibody Services Business (2016-2021)
11.7.5 Anaspec Recent Development
11.8 Bio-Rad
11.8.1 Bio-Rad Company Details
11.8.2 Bio-Rad Business Overview
11.8.3 Bio-Rad Antibody Services Introduction
11.8.4 Bio-Rad Revenue in Antibody Services Business (2016-2021)
11.8.5 Bio-Rad Recent Development
11.9 Covance
11.9.1 Covance Company Details
11.9.2 Covance Business Overview
11.9.3 Covance Antibody Services Introduction
11.9.4 Covance Revenue in Antibody Services Business (2016-2021)
11.9.5 Covance Recent Development
11.10 Capra Science
11.10.1 Capra Science Company Details
11.10.2 Capra Science Business Overview
11.10.3 Capra Science Antibody Services Introduction
11.10.4 Capra Science Revenue in Antibody Services Business (2016-2021)
11.10.5 Capra Science Recent Development
11.11 Innovagen
11.11.1 Innovagen Company Details
11.11.2 Innovagen Business Overview
11.11.3 Innovagen Antibody Services Introduction
11.11.4 Innovagen Revenue in Antibody Services Business (2016-2021)
11.11.5 Innovagen Recent Development
11.12 APS
11.12.1 APS Company Details
11.12.2 APS Business Overview
11.12.3 APS Antibody Services Introduction
11.12.4 APS Revenue in Antibody Services Business (2016-2021)
11.12.5 APS Recent Development
11.13 Randox
11.13.1 Randox Company Details
11.13.2 Randox Business Overview
11.13.3 Randox Antibody Services Introduction
11.13.4 Randox Revenue in Antibody Services Business (2016-2021)
11.13.5 Randox Recent Development
11.14 GL Biochem
11.14.1 GL Biochem Company Details
11.14.2 GL Biochem Business Overview
11.14.3 GL Biochem Antibody Services Introduction
11.14.4 GL Biochem Revenue in Antibody Services Business (2016-2021)
11.14.5 GL Biochem Recent Development
11.15 Abgent
11.15.1 Abgent Company Details
11.15.2 Abgent Business Overview
11.15.3 Abgent Antibody Services Introduction
11.15.4 Abgent Revenue in Antibody Services Business (2016-2021)
11.15.5 Abgent Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details